Who Owns Genelux Stock?
NASDAQ: GNLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 31.01%
- Held by insiders
- 12.87%
- Institutional holders
- 78
- Institutions 31.0%
- Insiders 12.9%
- Public and other 56.1%
Who owns Genelux stock?
Institutional investors own about 31.0% of Genelux's shares, spread across 78 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 12.87% of GNLX.
The largest institutional holders are Woodward Diversified Capital, LLC (5.00%), Vanguard Capital Management LLC (3.71%) and Bleichroeder LP (3.05%). Together, the top 10 institutions control 16.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their GNLX positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GNLX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Woodward Diversified Capital, LLC | 2.26M | 5.00% | +6.8% |
| Vanguard Capital Management LLC | 1.68M | 3.71% | -1.1% |
| Bleichroeder LP | 1.38M | 3.05% | 0.0% |
| Blackrock Inc. | 439.60K | 0.97% | +8.3% |
| Geode Capital Management, LLC | 439.21K | 0.97% | -3.2% |
| CM Management, LLC | 400.00K | 0.88% | +60.0% |
| Bank of America Corporation | 328.80K | 0.73% | +1.5% |
| Vanguard Fiduciary Trust Co | 236.34K | 0.52% | -6.1% |
| FLPutnam Investment Management Company | 231.41K | 0.51% | -17.6% |
| Global Retirement Partners, LLC | 227.85K | 0.50% | +5.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GNLX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.19M | 2.64% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 467.37K | 1.03% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 208.95K | 0.46% |
| iShares Trust-iShares Micro-Cap ETF | 137.14K | 0.30% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 63.95K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 62.09K | 0.14% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 34.32K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 26.48K | 0.06% |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 25.00K | 0.06% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 16.73K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Genelux?
Woodward Diversified Capital, LLC is the largest institutional shareholder of GNLX, owning 5.00% of shares outstanding (2.26M shares) as of its latest 13F filing.
What percentage of Genelux is owned by institutions?
Institutions own about 31.0% of GNLX shares and 35.6% of the public float.
How much of Genelux do insiders own?
Insiders, such as officers and directors, own about 12.87% of GNLX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.